HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Zacks Rank    Equity Research    Premium Home    My Account    Help    
11:59 pm TONIGHT!
Since August, 2007, if you invested in the market, you'd be down -24.3%. But a small group of Zacks investors has quietly gained +22.2%. They know where to find value stocks at just the right time. Don’t miss your chance. Deadline: 11:59 pm Saturday July 31 -- TONIGHT >>
Quote:
Login Free Membership
Search:

Analyst Blog  

Flagstone Outbids for IPC

July 02, 2009 | Comments: 0
Recommended this article (2)
FSR | IPCR | VR | MXGL
Print    Share

On July 1, Wednesday, Flagstone Reinsurance Holdings Limited (FSR - Snapshot Report) offered to buy IPC Holdings Ltd. (IPCR), which Flagstone said is superior to the Validus (VR - Snapshot Report) offer.

Flagstone has offered 2.638 of its common shares for each IPC common share plus $5.50 per share in cash, valuing IPCR at $33.62 per share. This results in a premium of 21.1% over IPCR’s Wednesday closing price of $27.77.

The Validus bid was 1.1234 of its shares plus $3.75 in cash, valuing IPCR at $28.86 a share. Following the announcement by Flagstone, Validus has "reaffirmed" its offer today.

Last week, IPCR’s Board had opposed the Validus offer, stating that it is at a discount to its book value. However, Validus refused to budge in economic terms, considering the offer to be "full and fair." IPCR had been negotiating with Validus while testing waters with other parties for the best deal.

The amalgamation agreement of IPCR with Max Capital Group Ltd (MXGL) was terminated on June 12, following the disapproval of the proposal by IPCR’s shareholder at its general meeting, though Max's stockholders had voted in favor of the amalgamation.

Merger and acquisition activity in the reinsurance sector has picked up in the second quarter, as companies with stronger balance sheets are considering expanding their platforms in markets which they found difficult to access previously.

We note that IPCR has built a track record of strong underwriting results while maintaining a strong balance sheet and ROE. The company is also poised to benefit from rates increases in 2009. Though there are a number of risks and uncertainties regarding IPCR now, we expect the amalgamation to benefit the shareholders of IPCR as a result of enhanced scale and size, coupled with an increased capital base. As such, we are reiterating our Hold recommendation on the shares of IPCR.

Email

Print

Share

RSS

Rate Pos

Rate Neg

Comment
Free Stock Analysis From Zacks
  Includes Zacks Long-Term Recommendation and Target Price
Read/Post Comments (0) | Recommended this article (2)
 Posting Comment...
There was a problem posting this this comment. Please try back later.
[CLICK TO CLOSE X]
Comments (Limit 1000 Characters - Used: 0)
Display Name: Email Address:  
 Loading Comments...
Be the first to comment on this article!
Best Stocks. Best Insight. Join Now...it's FREE!
Over 650,000 investors look forward to the timely insights in our email newsletter; Zacks Profit from the Pros. In each daily issue you will find:
  • Free  Four Zacks #1 Rank "Strong Buy" Stocks
  • Free  Timely Market Commentary
  • Free  Wealth Management Tips
  • Free  Profitable Strategy Screens
  • Free  Bull and Bear Stocks of the Day
Zacks FREE Registration

More Zacks Resources

Market Summary Jul 31, 2010 13:10 pm ET
DJIA 10465.94  -1.22 -0.01%
NASD 2254.7  3.01 0.13%
S&P 500 1101.6  0.07 0.01%
Partner Center